Pfizer will pay $35 million to resolve allegations by 42 states that its subsidiary, Wyeth Pharmaceuticals, illegally marketed an organ transplant drug for unapproved uses.
Aug 6, 2014
0
0
Socioeconomic status is a more important barrier to living kidney donation than cultural factors, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). The findings ...
Aug 29, 2013
0
0
The U.S. Justice Department said Tuesday that drugmaker Pfizer Inc. will pay almost $491 million to resolve an investigation into illegal marketing of the organ transplant drug Rapamune by a company Pfizer later acquired.
Jul 30, 2013
0
0
After receiving an organ transplant, patients must follow a regimented medication routine to maintain the health of their graft (transplanted organ). Failure to do so, known as non-adherence (NA), can result in life-threatening ...
Jun 4, 2013
0
0
A team led by Dr. Marie-Josée Hébert from the University of Montreal Hospital Research Centre (CRCHUM) has discovered a new cause of organ rejection in some kidney transplant patients. Her team has identified a new class ...
Feb 27, 2013
1
0
The head of the German doctors' lobby and politicians called Thursday for swift action to root out corruption following a scandal over preferential treatment for organ transplants.
Jan 3, 2013
0
0
(HealthDay) -- The first DNA test to help doctors treat a common viral infection in people who have had a solid organ transplant has been approved by the U.S. Food and Drug Administration.
Jul 5, 2012
0
0
Researchers at the Hofstra North Shore-LIJ School of Medicine and Feinstein Institute for Medical Research conducted a retrospective analysis which found that morbid obesity impedes kidney donation. In fact, in the analysis ...
May 10, 2012
0
0
There is an urgent need to increase the number of organ donors from black and minority ethnic (BME) groups in countries with a strong tradition of immigration, such as the UK, USA, Canada and the Netherlands, in order to ...
Feb 15, 2012
0
0
Transplant patients who develop head and neck cancer are more likely to be non-smokers and non-drinkers, and less likely than their non-transplant counterparts to survive past one year of diagnosis, according to a new study ...
Jan 28, 2012
0
0
